[
    "{\"step_by_step_thinking\": \"Bexarotene is not recommended for the treatment of relapsing-remitting multiple sclerosis (RRMS). Bexarotene is a retinoid receptor agonist that is primarily used for the treatment of cutaneous T-cell lymphoma. It has not been approved by regulatory authorities for the treatment of RRMS. The mainstay of treatment for RRMS includes disease-modifying therapies such as interferon beta, glatiramer acetate, and oral medications like dimethyl fumarate or fingolimod. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]